With a strong demand Growth in thehealthcarespace and people focusing more on preventative care after the outbreak of Covid-19 pandemic, pharma companies are adding more drugs and products to their existing portfolios.
As a result, there has been a substantial jump in productapprovalsgranted to manufacture medicines inGujarat.
For instance: Gujarat Food and Drug Control Administration (FDCA) in September issued 5,494 licences to make different allopathic drugs and products. Except January and April, the number of product permissions provided to pharma firms every month has hovered above the 5,000-mark this year, shows data compiled by the FDCA-Gujarat.
The issuance of fresh product licences started increasing after the pandemic and crossed the monthly mark of 5,000 in 2021. New product licences totalling 5,601, 5,324, 5,488 and 5,421 were issued by the state FDCA in April, May, June, July and August, respectively. The number stood at 5,095 in February and 5,123 in March this year. The product approvals were low at 3,981 and 3,725 in January and April, respectively, reveal the state FDCA data. As many as 48,909 product permissions have been issued by the state FDCA so far this year.